Surgical/endoscopic emergency in gastric/GEJ adenocarcinoma: massive upper-GI bleed requi...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-GASTRIC-EMERGENCY-BLEED-OBSTRUCTION |
|---|---|
| Type | Red flag |
| Status | reviewed 2026-04-26 | pending_clinical_signoff |
| Diseases | DIS-GASTRIC |
| Sources | SRC-ESMO-GASTRIC-2024 SRC-NCCN-GASTRIC-2025 |
Red Flag Origin
| Definition | Surgical/endoscopic emergency in gastric/GEJ adenocarcinoma: massive upper-GI bleed requiring transfusion, gastric outlet obstruction with intolerance of oral intake, or perforation. Mandates urgent endoscopic / surgical / interventional management BEFORE systemic therapy initiation. |
|---|---|
| Clinical direction | hold |
| Category | organ-dysfunction |
Trigger Logic
{
"any_of": [
{
"finding": "massive_upper_gi_bleed",
"value": true
},
{
"finding": "gastric_outlet_obstruction_npo",
"value": true
},
{
"finding": "gastric_perforation",
"value": true
}
],
"type": "composite_score"
}
Notes
~30% of gastric cancer presents with obstruction or bleeding. Endoscopic stenting OR palliative/diversion surgery + nutritional support BEFORE chemo. Bevacizumab/ramucirumab additionally contraindicated for ≥28 days post-surgery.
Used By
Algorithms
ALGO-GASTRIC-RESECTABLE-PERIOP- ALGO-GASTRIC-RESECTABLE-PERIOP
Indications
IND-GASTRIC-METASTATIC-1L-CLDN18-2-ZOLBETUXIMAB- IND-GASTRIC-METASTATIC-1L-CLDN18-2-ZOLBETUXIMABIND-GASTRIC-METASTATIC-1L-FGFR2B-BEMARITUZUMAB- IND-GASTRIC-METASTATIC-1L-FGFR2B-BEMARITUZUMABIND-GASTRIC-METASTATIC-1L-HER2-TOGA- IND-GASTRIC-METASTATIC-1L-HER2-TOGAIND-GASTRIC-METASTATIC-1L-PDL1-CHEMO-ICI- IND-GASTRIC-METASTATIC-1L-PDL1-CHEMO-ICIIND-GASTRIC-METASTATIC-2L-HER2-TDXD- IND-GASTRIC-METASTATIC-2L-HER2-TDXDIND-GASTRIC-METASTATIC-2L-RAMUCIRUMAB-PACLITAXEL- IND-GASTRIC-METASTATIC-2L-RAMUCIRUMAB-PACLITAXELIND-GASTRIC-OLIGOMET-SYSTEMIC-PLUS-LOCAL- IND-GASTRIC-OLIGOMET-SYSTEMIC-PLUS-LOCALIND-GASTRIC-PERIOP-FLOT4- IND-GASTRIC-PERIOP-FLOT4